Cumulative radiation exposure from imaging procedures and associated lifetime cancer risk for patients with lymphoma

The aim of this study was to systematically evaluate the cumulative radiation exposure and the associated lifetime-cancer-risk from diagnostic imaging in patients with Hodgkin-lymphoma-(HL) or diffuse-large-B-cell-lymphoma (DLBCL). 99 consecutive patients (53-males) diagnosed with HL or DLBCL were included in the study and followed. Based on the imaging reports, organ and effective-doses-(ED) were calculated individually for each patient and the excess lifetime risks were estimated. The average ED in the first year after diagnosis was significantly different for men (59 +/- 33 mSv) and women (744 +/- 33 mSv)-(p < 0.05). The mean cumulative ED in each of the following 5 years was 16 +/- 16 mSv without significant differences between men and women-(p > 0.05). Over all years, more than 90% of the ED resulted from CT. The average cumulative radiation risk estimated for the first year was significantly lower for men (0.76 +/- 0.41%) as compared to women (1.28 +/- 0.54%)-(p < 0.05). The same was found for each of the subsequent 5-years (men-0.18 +/- 0.17%; women-0.28 +/- 0.25%)-(p < 0.05). In conclusion, for HL and DLBCL patients investigated in this study, a cumulative radiation risk of about 1 excess cancer per 100 patients is estimated for diagnostic imaging procedures performed during both the first year after diagnosis and a follow-up period of 5 years.